Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines.
Saved in:
| Title: | Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines. |
|---|---|
| Authors: | Graciotti M; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland., Marino F; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland., Pak H; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland., Baumgaertner P; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland., Thierry AC; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland., Chiffelle J; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland., Perez MAS; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland., Zoete V; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland., Harari A; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland., Bassani-Sternberg M; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland., Kandalaft LE; Department of Oncology, Ludwig Institute for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland.; Center of Experimental Therapeutics, Department of Oncology, University Hospital of Lausanne (CHUV), 1011 Lausanne, Switzerland. |
| Source: | Vaccines [Vaccines (Basel)] 2020 Jun 02; Vol. 8 (2). Date of Electronic Publication: 2020 Jun 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2076-393X |
|---|---|
| DOI: | 10.3390/vaccines8020271 |
